An Escherichia coli K-12 model system was developed for studying the VanS-VanR two-component regulatory system required for high-level inducible vancomycin resistance in Enterococcus faecium BM4147. Our model system is based on the use of reporter strains with lacZ transcriptional and translational fusions to the P vanR or P vanH promoter of the vanRSHAX gene cluster. These strains also express vanR and vanS behind the native P vanR promoter, the arabinose-inducible P araB promoter, or the rhamnose-inducible P rhaB promoter. Our reporter strains have the respective fusions stably recombined onto the chromosome in single copy, thereby avoiding aberrant regulatory effects that may occur with plasmid-bearing strains. They were constructed by using allele replacement methods or a conditionally replicative attP plasmid. Using these reporter strains, we demonstrated that (i) the response regulator VanR activates P vanH , but not P vanR , expression upon activation Vancomycin is a glycopeptide antibiotic that is currently used for the treatment of gram-positive bacterial infections, especially ones caused by methicillin-resistant Staphylococcus aureus species (49). Vancomycin acts by binding to the terminal D-Ala-D-Ala moieties of bacterial cell wall precursors and effectively inhibits the transpeptidation and transglycosylation steps of the cell wall assembly process, thereby rendering the cell susceptible to osmotic shock. Over the past 10 years, a number of Enterococcus strains with high-level inducible resistance to vancomycin have been identified (11), and the relative incidence of these strains has increased sharply in the last 3 years (39). High-level resistance to the antibiotic has been found to require five plasmid-borne genes : vanR, vanS, vanH, vanA, and vanX. VanR and VanS comprise a two-component regulatory system (2, 51) that regulates transcription of the genes responsible for conferring resistance: vanH, vanA, and vanX (52). Twocomponent regulatory systems are signal transduction pathways commonly used by prokaryotes to sense and adapt to stimuli in the environment; as many as 50 different ones may exist in a single bacterium such as Escherichia coli (29). Analogous signal transduction pathways have recently been identified in both eucaryotes (38) and archaea (32). These systems are characterized by a sensor histidine kinase (often a transmembrane signaling kinase such as VanS) that undergoes autophosphorylation on a conserved histidine residue. The phosphoryl group is then transferred to a conserved aspartate residue on the response regulator protein (in this case, VanR) that usually acts as a transcriptional activator. Like many signaling kinases, VanS has an N-terminal domain with two transmembrane segments flanking an extracellular domain that is believed to act as the signal sensing domain and a C-terminal cytoplasmic transmitter domain with autophosphorylation and phosphotransfer activities. Biochemical studies on the cytoplasmic domain of VanS (M95 to S384) have shown that it is readily autophosphorylated on a histidine residue (H164) in the presence of ATP and that phospho-VanS (P-VanS) is capable of efficient phosphotransfer to an aspartate residue on VanR (D53) (51). Genetic studies have implicated VanR as a transcriptional activator of the vancomycin resistance genes (2). To date, two VanR-responsive promoters have been identified: the promoter P vanR , for expression of vanRS, and the promoter P vanH , for expression of vanHAX. The in vivo transcriptional start site of P vanH (but not of P vanR ) has also been mapped. Studies using purified VanS and VanR have validated these predictions. Gel mobility shift analyses have shown that P-VanR has a greater binding affinity than the nonphosphorylated protein for both promoter regions of the vancomycin resistance operon, with the strongest binding near P vanH (50% effective concentration of 40 nM [15] ). DNase I footprinting analyses have suggested that VanR forms an oligomeric struc-
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In addition to activation of VanR, the cytoplasmic domain of VanS is also capable of in vivo activation and in vitro phosphorylation of the E. coli response regulator PhoB (8) . In wild-type cells, PhoB, together with its cognate sensor kinase PhoR, controls the expression of the Pho regulon in response to inorganic phosphate (P i ) limitation (44) . This cross-reactivity between VanS and PhoB has provided a convenient in vivo assay for VanS activation and has allowed for genetic analyses on the factors that regulate the VanS-VanR two-component signal transduction system. For example, we have identified peptide fragments of VanS capable of inhibiting activation of PhoB by VanS (8) . These fragments may correspond to an interaction domain. We have also exploited this system to identify critical residues of PhoB that are involved in the phosphotransfer pathway and recognition of VanS (12) . These studies relied upon PhoB being a poor substrate for phosphotransfer from P-VanS; biochemical studies have shown that the kinetic efficiency (k cat /K m ) is 10,000-fold higher for VanR than that measured for PhoB (9) . This large kinetic difference between VanR and PhoB as substrates for P-VanS prompted us to develop an in vivo E. coli reporter system to study VanR phosphorylation and transcriptional activation. It was felt that this system would not only give an important reference point for our studies on VanS and PhoB but would also provide a genetic system to analyze VanR structure-function relationships in vivo, as well as an additional, potentially more sensitive in vivo assay of VanS activation.
Here we describe the regulation of the P vanR and P vanH promoters of the vanRSHAX gene cluster by VanR and VanS in an E. coli model system. By use of the appropriate strains, we examined the in vivo activation of VanR by VanS, mutant forms of VanS, the nonpartner sensor kinase PhoR, and acetyl phosphate. We also tested whether VanS, like many two-component histidine kinases, has a dual role and is required for both the activation of VanR and deactivation of P-VanR. Our results are discussed.
MATERIALS AND METHODS
Media, chemicals, and other reagents. Most materials have been described elsewhere (43) . Luria-Bertani, tryptone-yeast extract (TYE), and glucose M63 agar media were routinely used as complex and minimal agar. 5-Bromo-4-chloro-3-indolyl-␤-D-galactopyranoside (X-Gal) was used at 40 g per ml for detection of ␤-galactosidase. All regulation studies were carried out with broth or agar media buffered with 3-(N-morpholino)propanesulfonic acid (MOPS) and containing 2 mM P i unless indicated otherwise. MOPS agar media contained 0.2% D-glucose, D-fructose, D-gluconate, glycerol, or 1% pyruvate as the sole carbon source without or with 1.3 mM L-arabinose or 1.1 mM L-rhamnose. Most antibiotics and chemicals were from Sigma (St. Louis, Mo.) and were used at the following concentrations: ampicillin at 100 g per ml to maintain plasmids; kanamycin at 10 or 50 g per ml to select kanamycin-resistant (Kan r ) integrants or maintain plasmids, respectively; and tetracycline at 12.5 g per ml to select tetracycline-resistant (Tet r ) transductants. Except for plasmid-bearing strains, cells were routinely grown without an antibiotic. Taq DNA polymerase (Promega, Madison, Wis.) was used for testing the copy number of an integrated plasmid. Vent DNA polymerase (New England Biolabs, Beverly, Mass.) was used to generate DNAs for cloning. Oligonucleotides were obtained from IDT, Inc. (Coralville, Iowa).
Bacteria. Unless noted otherwise, bacteria are derivatives of E. coli K-12 strain BW13711 (43) and were constructed by P1kc transduction (43) . Strain constructions usually involved two steps. In the first step, a linked auxotrophic (or carbon utilization negative) marker was introduced by selecting Tet r transducants. These transductants were then made prototrophic (or carbon utilization positive) with P1kc grown on an appropriate donor, and the resultant transductants were scored for loss of antibiotic resistance and other relevant phenotypes. All strains assayed are described in Table 1 [20] ), BW21254 (⌬creABCD154 [19] ), BW22826 (⌬araBAD AH33 [13] ), and JW383 (zii-510::Tn10 metF159 [obtained from M. Berlyn]); only relevant markers are indicated. The constructions of BW21437 (⌬ackA158), BW21530 (⌬phoR574), BW21770 (⌬ackA159), BW22623 (⌬pta-163), BW22624 [⌬(ackA pta)160], and BW23231 (⌬phoBR580) are described below. Plasmids requiring the ⌸ protein (the pir gene product) for replication were maintained in BW23473 (pir ϩ hsdR514 endA recA1 [12] ), BW23474 (pir-116 hsdR514 endA recA1 [12] ), or other appropriate hosts (26) .
Construction of ⌬ackA, ⌬pta, and ⌬(ackA pta) mutants. Four deletions of the ackA-pta region were constructed. The ⌬ackA158 and ⌬ackA159 mutations remove a 0.4-kbp KpnI and a 1.1-kbp ScaI-to-KpnI fragment internal to ackA, respectively; the ⌬(ackA pta)160 mutation removes a 2.5-kbp XmnI fragment internal to the adjacent ackA and pta genes; the ⌬pta-163 mutation removes a 1.7-kbp PshAI-to-BamHI fragment internal to pta (Fig. 1A ). An allele replacement plasmid carrying ⌬ackA158 was made in three steps. First, the 5.2-kb MluI fragment of pMK800 (obtained from A. Nakata [23] ) was deleted to make pLD56; second, the KpnI fragment was deleted to make pLD57; then, the 7.4-kbp BamHI fragment containing the ⌬ackA158 mutation was cloned into the vector pLD53 (26) . The resultant plasmid pLD62 was used to recombine the ⌬ackA158 mutation onto the chromosome of BW13711. Tet r transformants were selected following electroporation; after being purified once in the absence of tetracycline, tetracycline-sensitive recombinants were selected as described previously (27) . Ones showing an AckA Ϫ phenotype (poor growth with acetate as a carbon source and fluoroacetate resistance) were verified as described elsewhere (26) . A plasmid carrying the ⌬ackA159 mutation was made in two additional steps. First, pLD57 was digested with ScaI, ligated to a KpnI linker (phospho-GGGTACCC), digested with KpnI, and religated to make pLD58; then the 6.7-kb BamHI fragment containing the ⌬ackA159 mutation was cloned into pLD53; the resultant plasmid pLD63 was used to recombine the ⌬ackA159 mutation onto the chromosome of BW21254 as described above.
To construct the ⌬(ackA pta)160 and ⌬pta-163 mutations, the ackA-pta chromosomal region was first cloned using the mini-Mu vector pMW11 (50) by complementation of the phoR creC ⌬(ackA pta) TA3516 mutant BW21073 (6) . Overproduction of AckA and Pta from a multicopy plasmid presumably leads to increased acetyl phosphate levels, resulting in activation of PhoB in the absence of PhoR and CreC and consequent expression of phoA. Transductants expressing phoA at a high level were screened for ones that, based on the restriction pattern, carried plasmids for the ackA-pta region. The 4.3-kbp MluI-to-SmaI fragment of one such plasmid was subcloned into EcoRV-and MluI-digested pLITMUS38 (New England Biolabs); the resultant plasmid was named pAH24. The XmnI fragment was deleted from pAH24 to create pAH25 with the ⌬(ackA pta)160 mutation. pAH24 was also digested with BamHI, filled in with T4 DNA polymerase, digested with PshAI, and religated to create pAH27 with the ⌬pta-163 mutation. The 1.7-and 2.8-kbp SalI-to-SpeI fragments of pAH25 and pAH27 were subcloned into pWM45 (26) to make pAH28 and pAH29, respectively. The latter were used to recombine the ⌬(ackA pta)160 and ⌬pta-163 mutations onto the chromosome of BW21591 (⌬phoR574 ⌬creBCD153 [this study]) as described above.
Construction of ⌬phoR and ⌬phoBR mutants. Two deletions of the phoBR operon (Fig. 1B) were made. The ⌬phoR574 mutation removes 1.3 kbp including the entire phoR coding region; the ⌬phoBR580 mutation removes 2.0 kbp of the entire phoBR operon. pBC6⌬PstI (46) contains the phoBR operon within a 4.7-kbp HindIII-to-EcoRI fragment. pSK2 (9) carries the same region in which NdeI and BamHI sites were introduced by site-specific mutagenesis at the phoB start codon and 13 bp beyond the phoB stop codon, respectively. The phoB stop codon precedes the phoR start codon by 60 bp. A native AseI site lies at the phoR stop codon. The ⌬phoR574 mutation was made by joining the 0.5-kbp SmaI-toBamHI fragment for the 3Ј end of phoB to the 1.3-kbp AseI-to-EcoRI fragment immediately downstream of the phoR coding region. To do this, pBC6⌬PstI was digested with AseI, filled in with T4 DNA polymerase, and digested with EcoRI. The released 1.3-kbp fragment was ligated to SmaI-and EcoRI-cut pBlueScriptIISKϪ (Stratagene, La Jolla, Calif.) to make pAH7. The same region was then subcloned from pAH7 as a BamHI-to-SalI fragment into pWM45 to make pAH12. pSK2 was cut with SmaI, ligated to a NotI linker (phospho-TTGCGGCCGCAA), and then digested with NotI and BamHI, after which the released 0.5-kbp fragment was ligated to similarly cut pAH12 to make pAH14. The latter was used to recombine the ⌬phoR574 mutation onto the chromosome of BW13711; recombinants were verified as described elsewhere (26) .
A complete phoBR deletion was made by using pAH7 and pSK47 (19) . The latter has the 4.7-kbp PstI-to-EcoRI phoBR operon fragment of pSK2 (Fig. 1B) cloned into the backbone of pSK50⌬uidA2 (12, 19) . The 2.6-kbp fragment of pSK47 containing phoR and brnQЈ was replaced with the 1.3-kbp fragment of a All bacteria are derivatives of E. coli K-12, except that the phn(EcoB) locus is from E. coli B (45) . b All known mutations are given. The prime (Ј) signifies that the gene is deleted on the side of the prime. The subscript T14 refers to four tandem copies of the rrnB terminator. The subscript TA3516 refers to the name of the original strain in which this deletion arose (48) . Other subscripts correspond to plasmids carrying the original deletion or fusion that was recombined onto the chromosome by allele replacement. In another study, we recently discovered that the E. coli K-12 strain BD792 and its descendants contain an rpoS(Am) mutation present also in many other E. coli K-12 lines (17) .
c The parental strain from another laboratory and its most immediate ancestor in this laboratory. d See Materials and Methods.
pAH7 containing only brnQЈ. To do this, pSK47 was digested with BamHI, filled in, and then digested with EcoRI; pAH7 was digested with SacI, filled in, and then digested with EcoRI. The appropriate fragments were joined to create pLD86. To delete phoB, pLD86 was digested with NdeI and SacII, filled in, and religated. The resultant plasmid pLD88 was used to recombine the ⌬phoBR580 mutation onto the chromosome of BW22878 (pstS21 [this study]). Construction of lacZ transcriptional and translational fusions. pSLF48 has a lacZ transcriptional, operon [lacZ(op)] fusion to P vanH ; pSLF70 has a lacZ translational, protein [lacZ(pr)] fusion to the start codon of vanR; pSLF71 and pSLF74 have lacZ(pr) fusions to the start codon and codon 100 of vanH, respectively. pSLF48 was made by cloning the 747-bp EcoRI-to-SalI fragment for the P vanH promoter region of pAT89 (2) into pWJ13 (17) . pSLF70, pSLF71, and pSLF74 were constructed by cloning PCR-generated fragments using the respective P vanH and P vanR primers (Table 2 ). These were cloned as blunt or PstI-toBamHI fragments into pSPORT1 (Gibco-BRL, Bethesda, Md.) for DNA sequencing to create pSLF69, pSLF68, and pSLF75, respectively, and then subcloned as PstI-to-BamHI fragments into pWJ20 (17) . pWJ13 and pWJ20 are derivatives of pLD53 (26) that allow for construction of lacZ(op) and lacZ(pr) fusions, respectively, that can be recombined onto the E. coli chromosome at the lac locus by allele replacement, effectively replacing lacP with the respective foreign promoter. pWJ13 contains the polylinker region including the RNase III processing site preceding lacZ in pTL61L (obtained from T. Linn [24] ). pWJ20 has the same polylinker region joined to the BamHI site at codon 8 of lacZ in pRS414 (obtained from R. Simons [35] ).
Construction of phoR, vanR, and vanS plasmids. pAH35 encodes full-length PhoR (residues M1 to D431); pAH41 encodes an N-terminal truncated PhoR (residues M63 to D431; denoted ЈPhoR) with an N-terminal FLAG epitope, denoted NFLAG; pAH44 encodes full-length VanS (residues M1 to S384); pAH49 encodes an N-terminal truncated VanS (residues M95 to S384; denoted ЈVanS); pAH52 encodes full-length VanS (residues M1 to S384) in which its autophosphorylation (H164) site has been changed to glutamine; and pSLF46 encodes a similar N-terminally truncated VanS (residues M95 to S384 with the H164Q change). These plasmids are derivatives of pAH33, a vector for constructing fusions to P araB that can be recombined onto the chromosome at the araCBAD locus by allele replacement (13) . The resulting recombinants express the corresponding phoR or vanS coding region behind the arabinose-regulated P araB promoter. The required fragments were generated by PCR, cloned into pSPORT1, pSPORT1::merR, or pSPORT1::NFLAG-merR (obtained from B. Ballard), and then subcloned into pAH33 by using compatible sites. pSPORT:: merR and pSPORT1::NFLAG-merR contain a synthetic merR (5) without or with an NFLAG sequence. pSLF55 ( Fig. 2) expresses vanR under control of P vanR in a Kan r attP suicide vector with the R6K␥ plasmid replication origin (oriR R6K␥ ). pSLF55 was con- (46), pSK2 (9), and pSK47 (19) is shown. Sites with an asterisk are present only in pSK2 and pSK47; these were introduced by sitedirected mutagenesis. The truncated arrowhead indicates that the 3Ј end of sbcD is absent in these plasmids. structed in two steps. First, the NdeI-to-BamHI fragment encoding PhoB in pSK49 (12) was replaced with a similar fragment encoding VanR. The resultant plasmid was named pSLF49. Then the upstream region was replaced with the PstI-to-NdeI fragment of pSLF70 containing P vanR . pSLF60 and pSLF63 are derivatives of pLD78, a vector for cloning fragments adjacent to P rhaB that can be recombined onto the chromosome at the rhaRSBAD locus by allele replacement (6) . These plasmids contain also P vanR . Hence, pSLF60 and pSLF63 express vanR and vanRS, respectively, under control of P vanR . In pSLF63, but not in pSLF60, the respective insert is in line behind P rhaB , thus allowing also for rhamnoseactivated transcription of vanRS expression.
Molecular biology. The fragments encoding full-length and truncated PhoR were generated by using primers P109 and P110 and primers P95 and P96 (Table  2) , respectively. The fragments encoding full-length VanS and VanS H164Q were generated by using the vanS1 primers; the fragments encoding truncated ЈVanS and ЈVanS H164Q were generated by using the vanS2 primers. The fragment encoding VanR was generated by using the vanR primers. The 261-bp P vanR fragment in pSLF70 was generated by using the 5Ј and 3Ј P vanR primers (Table  2) ; the 222-bp P vanH fragment in pSLF71 was generated by using the P vanH1 primers; the 747-bp P vanH fragment in pSLF74 was generated by using the P vanH2 primers. The phoR fragments were generated by using pBC6⌬PstI (46) as the template. All van sequences were amplified by using pAT89 or a subclone carrying wild-type or appropriate mutant DNA as the template. Particular 5Ј extensions were in some cases complementary to adjacent vector sequences. All PCR-amplified DNAs were sequenced on both strands, using dye terminators and an Applied Biosystems model 373A automated sequencer at the Dana Farber Cancer Institute Molecular Biology Core Facility (Harvard Medical School, Boston, Mass.).
attP plasmid integration. Integration of oriR R6K␥ attP plasmids was done by using pINT-ts essentially as described elsewhere (12) . pINT-ts is an ampicillinresistant, low-copy-number plasmid with a temperature-sensitive replicon which synthesizes integrase (Int) under the control of cI857 (14) . It is therefore temperature sensitive for plasmid replication; it also expresses int upon shift to elevated temperatures (above 37°C). An ampicillin-resistant transformant carrying pINT-ts was grown in S.O.B. medium (33a) with ampicillin (100 g per ml) at 30°C, transformed with pSLF55 by electroporation as described previously (26) , incubated at 37°C for 1 h and 43°C for 30 min, spread onto TYE agar containing kanamycin (10 g per ml), and incubated at 37°C. Several Kan r colonies were purified on TYE agar (without kanamycin), screened for ampicillin-sensitive ones (to verify loss of pINT-ts), and then tested for copy number. Once constructed, integrants were routinely grown in the absence of antibiotic selection.
PCR testing of copy number. Two primers specific for the vector attP region (P2 and P3 [ Table 2 ]) and two specific for the chromosomal attB region (P1 and P4 [ Table 2 ]) were used to test integrants for ones with a single copy of the integrated plasmid at att. These primers were designed so that a nonintegrant was expected to yield a 231-bp PCR fragment with P1 and P4 (attB pair), a single-copy integrant was expected to yield a 327-bp PCR fragment with P1 and P2 (attL pair) and a 592-bp PCR fragment with P3 and P4 (attR pair), and a double (or higher-multiple) integrant was expected to yield the 327-and 592-bp PCR fragments of a single integrant and in addition a 698-bp PCR fragment with P2 and P3 (attP pair). Fragments of these sizes were obtained when nonintegrant, single-integrant, and double (or multiple)-integrant control strains were tested (data not shown).
PCR was performed directly, using bacterial colonies essentially as described elsewhere (3, 20) . Cells were transferred with a glass capillary tube into 20 l of lysis solution (1ϫ PCR buffer [Promega] containing 2.5 mM MgCl 2 , 0.1 mg of nuclease-free bovine serum albumin per ml, 0.05 mg of proteinase K per ml, 20 mM dithiothreitol, and 1.8 M sodium dodecyl sulfate). These mixtures were incubated at 37°C for 30 min and then heated to 95°C for 5 min. Then 5 l of lysed cells, 50 pmol of each primer P1 to P4, and 2 U of Taq DNA polymerase (Promega) were combined to form a 100-l mixture containing 1ϫ PCR buffer, 2.5 mM MgCl 2 , and 200 M each deoxynucleoside triphosphate. PCR was carried out for 25 cycles (denaturing for 1 min at 94°C, annealing for 1 min at 63°C, and extending for 1 min at 72°C).
Cell growth and enzyme assay. Cells were pregrown on minimal MOPS agar with the same carbon source but without an inducer, and isolated colonies were inoculated into 0.06% glucose-MOPS, 0.06% D-gluconate-MOPS, 0.06% fructose-MOPS, 0.1% glycerol-MOPS, or 0.1% potassium pyruvate-MOPS medium without or with 1.3 mM L-arabinose or 1.1 mM L-rhamnose and grown for 16 to 24 h. Such carbon-limited cultures yield highly reproducible values that are qualitatively similar to ones obtained for logarithmic-growth-phase cultures. ␤-Galactosidase and bacterial alkaline phosphatase (Bap) activities were measured as described elsewhere (43) . ␤-Galactosidase units are nanomoles of o-nitrophenol made per minute at 28°C; Bap units are nanomoles of p-nitrophenol made per minute at 37°C.
RESULTS
An E. coli reporter system for studying the Enterococcus faecium VanS-VanR two-component regulatory system. Several transcriptional and translational fusions of the Enterococcus faecium BM4147 P vanH promoter and the vanH and vanR translational start sequences to E. coli lacZ were constructed to determine whether VanR of Enterococcus is capable of regulating transcription in E. coli. The lacZ fusions were constructed in vitro and then recombined onto the chromosome of an appropriate host as described in Materials and Methods. The resultant recombinants have in single copy at the lac locus the entire lacI gene followed by multiple tandem copies of the rrnB terminator and the foreign promoter (P vanH or P vanR ) driving lacZYA expression (17) .
Most experiments used strains carrying vanR in single copy and were constructed with pSLF55, which expresses vanR from its native promoter (Fig. 2) . pSLF55 is a derivative of the oriR R6K␥ attP plasmid pSK49 (12) . An oriR R6K␥ attP plasmid requires the trans-acting ⌸ protein (the pir gene product) for DNA replication; it integrates efficiently upon transformation of a non-pir host when Int is supplied in trans (Fig. 3) . Indeed, the majority of recombinants contain the plasmid at attB in single copy, which was verified by PCR testing as described in Materials and Methods. Strains with vanR expressed from its native promoter in single copy were used because preliminary experiments showed that VanR activates transcription in the absence of its cognate kinase when synthesized from a multicopy plasmid or from the strong P tac promoter even when in single copy (data not shown). Presumably, VanR when overproduced is activated (phosphorylated) nonspecifically by a noncognate kinase(s). Similar effects resulting from overproduction have also been observed for activation of PhoB in the absence of the kinases PhoR and CreC and acetyl phosphate synthesis (19) .
The arabinose-regulated P araB promoter was used for conditional synthesis of the kinases VanS and PhoR. Plasmids carrying various P araB -vanS or P araB -phoR fusions were constructed as described in Materials and Methods and then used to recombine each fusion onto the chromosome by allele replacement. The resultant recombinants contain vanS or phoR expressed from P araB in place of araBAD at the araCBAD locus (13) . Strains carrying these fusions in single copy were made in order to minimize aberrant regulatory effects due to overproduction of these kinases. Preliminary experiments also indicated that, as expected, strains with a single-copy P araB fusion show tighter control by arabinose than ones with a similar fusion on a multicopy P araB plasmid (8, 10). Individual strains have also various phoBR, creBC, ackA, and pta deletions. Most of these deletions are well defined, as they were made in vitro and recombined onto the chromosome by allele replacement as described in Materials and Methods. Strains with phoBR and creBC deletions were used to prevent interference by these chromosomally encoded response regulators and sensor kinases. Strains with ⌬ackA, ⌬pta, and ⌬(ackA pta) mutations were used to test for effects of acetyl phosphate on activation of VanR or to prevent gratuitous activation of VanR by acetyl phosphate, as many response regulators including VanR are known to be activated (phosphorylated) by acetyl phosphate in vivo and in vitro (reviewed in reference 47). Phosphotransacetylase (the pta gene product) and acetate kinase (the ackA gene product) are responsible for acetyl phosphate synthesis. An ackA mutation results in accumulation of acetyl phosphate during growth on carbon sources metabolized via glycolysis; a pta mutation blocks acetyl phosphate synthesis during growth on glycolytic substrates; and a ⌬(ackA pta) mutation blocks synthesis under all conditions (48) .
Transcriptional activation by VanR in E. coli. All of the P vanH -and P vanR -lacZ fusions are expressed in E. coli, although there are substantial differences in their levels of expression (Table 3 ). All three P vanH -lacZ fusions, but not the single P vanR -lacZ fusion, also show higher expression when both VanR and VanS (or PhoR) are present. In these experiments, vanR is expressed from its own promoter, while vanS and phoR are expressed from the arabinose-inducible P araB promoter. Since expression of P araB is also governed by catabolite repression, we examined effects during growth on fructose and glycerol media. In general, similar effects were observed with both carbon sources. Hence, in the presence of arabinose, the amount of VanS or PhoR is not limiting due to catabolite repression. When differences are seen, higher activation results during growth on glycerol than on fructose, as expected. Under all conditions, the P vanH -lacZ transcriptional fusion shows much higher expression than either of the P vanH -lacZ translational fusions. The reason for this is unclear. The P vanH transcriptional, but not the translational, fusion shows also substantial expression even in the absence of VanR. Nevertheless, activation of all three P vanH -lacZ fusions by VanR always requires a kinase, as shown by the arabinose-dependent synthesis.
During growth on fructose, the P vanH -lacZ transcriptional fusion strains synthesize, on average, ca. 42 U of ␤-galactosidase per cell OD 420 (optical density at 420 nm) in the absence of a kinase (no arabinose [ Table 3 Although the synthesis levels are considerably lower, both P vanH -lacZ translational fusions are also activated by VanR and VanS (compare values without and with arabinose for BW24025 and BW24086 [ Table 3 ]). The expression of both P vanH -lacZ translational fusions also requires VanR (data not shown). In these experiments, no activation of VanR results upon synthesis of the C-terminal kinase domains (ЈPhoR, ЈVanS, and ЈVanS H164Q ), regardless of the P vanH -lacZ fusion tested, suggesting that these kinases are less active. The results also show that both VanS and PhoR activate VanR in the absence of a (known) signal. Apparently, activation of VanR by VanS is a consequence of its overproduction from P araB . Activation of VanR by PhoR no doubt results from crossreactivity and is therefore unlikely to respond to a specific signal.
The lower expression levels of the P vanH -lacZ translational fusions may be due to inefficient translation initiation, an altered lacZ N terminus in these fusions, mRNA instability, or another difference. The predicted N terminus of these P vanHlacZ translational fusions is MTDPV, where V corresponds to residue 10 of ␤-galactosidase. The P vanH -lacZ transcriptional and P vanH -lacZ(pr)2 translational fusions have the same vanS upstream sequence; the P vanH -lacZ(pr)1 translational fusion has a shorter upstream region (see Materials and Methods). The cause of the different expression levels is unknown.
We also tested for regulation of a P vanR -lacZ translational fusion. In contrast to the P vanH -lacZ fusions, no effect on expression of the P vanR -lacZ translational fusion is apparent due to the presence of VanR alone or VanR and VanS together (compare values for BW24066 and BW24065 in Table 3 ). In both the presence and absence of VanR, P vanR is expressed at a low level (data not shown). The small effects seen in Table 3 may be attributed to experimental fluctuation in these physiology experiments.
Inhibitory effect of VanS on activation of VanR by PhoR. VanS may also act as a P-VanR phosphatase, by analogy to PhoR and a number of other sensor kinases. Both in vitro and in vivo studies also suggest that VanS has a dual role as a kinase (and phosphotransferase) and phosphatase (1, 51) . Therefore, we used our E. coli VanS-VanR reporter system to test whether VanS is a P-VanR phosphatase. If VanS is a P-VanR phosphatase, then VanS should interfere with activation of VanR by PhoR. However, since activation of VanR occurs in the absence of a signal when VanS is overproduced, it was necessary to avoid overproduction of VanS in order to test its phosphatase function. We therefore constructed reporter strains with the vanR or vanRS operon on the chromosome at the rhaRSBAD locus in place of rhaBAD (6) . The strain with vanRS also has the rhamnose-regulated P rhaB promoter upstream of P vanR (see Materials and Methods).
In the vanR strains BW23734 and BW23670, the P vanH -lacZ transcriptional fusion produces ca. 50 U of ␤-galactosidase per cell OD 420 (Table 4 ). The otherwise isogenic vanRS strains BW23715 and BW23671 produce similar amounts of ␤-galactosidase. This amount increases about 14-fold upon induction of PhoR synthesis in the vanR strain BW23670. No further increase is evident when the same strain is subjected to P i limitation, the normal signal for activation of PhoR (44) . In contrast, no significant activation occurs upon induction of PhoR synthesis when VanS is present, as in the vanRS strain BW23671. Therefore, VanS interferes with activation of VanR by PhoR, probably because VanS acts as a P-VanR phosphatase.
An additional experiment was done to rule out a trivial explanation for the foregoing results. Since no activation of the P vanH -lacZ fusion was ever seen in the vanRS strain BW23715, we considered that a mutation may have fortuitously arisen during its construction. To rule this out, we tested for the effect of rhamnose on activation because the vanRS operon lies immediately downstream of the P rhaB promoter in BW23715. Consequently, rhamnose should induce VanR and VanS synthesis. As shown in Table 5 , growth on rhamnose results in more than fourfold activation of the P vanH -lacZ fusion in this strain. Therefore, the vanRS operon appears to be normal in BW23715, and VanS interferes with activation of VanR by PhoR in the absence of a signal.
Activation of VanR by acetyl phosphate.
Reporter strains were also used to test for activation of VanR by acetyl phosphate and to determine whether VanS acts as a P-VanR phosphatase under these conditions. BW24386 and BW24387 accumulate acetyl phosphate due to an ackA mutation (48) . The former strain has vanR alone; it produces ␤-galactosidase from the P vanH -lacZ fusion at a high level (ca. 300 U per cell OD 420 [ Table 6 ]), thus showing that acetyl phosphate activates VanR in vivo. The latter has vanRS; it produces ␤-galactosidase at a lower level (ca. 50 U per cell OD 420 ) that is also characteristic for expression of this fusion in the absence of VanR. These data show that VanS also interferes with activation of VanR by acetyl phosphate, providing further evidence that VanS acts as a P-VanR phosphatase. These strains are also phoB ϩ ⌬phoR ⌬creC. As expected, they synthesize Bap at a high level (ca. 400 U per cell OD 420 ). Similar strains produce Ͻ1 U of Bap per cell OD 420 in the absence of PhoR, CreC, and acetyl phosphate synthesis (20, 48) . We also showed that activation of VanR in these experiments is a consequence of acetyl phosphate synthesis by comparing the effects of ⌬pta, ⌬ackA, and ⌬(ackA pta) mutations during growth on various carbon sources (data not shown).
In preliminary experiments, we tested for activation of VanR by acetyl phosphate in Pta ϩ AckA ϩ strains during growth on pyruvate and gluconate media. Growth on these carbon sources is expected to result in elevated acetyl phosphate levels (25, 48) . Yet no activation of VanR was apparent under these conditions, even though the same cultures showed elevated Bap synthesis (data not shown). Apparently, activation of VanR requires greater amounts of acetyl phosphate than activation of PhoB. No experiment was done to determine whether activation of VanR by acetyl phosphate is a direct autophosphorylation reaction or an indirect one, as can occur for PhoB (20, 42) . (Table 3) . We also examined whether H164 is required for deactivation (dephosphorylation) of P-VanR. To do this, we compared effects of VanS and VanS H164Q on activation of VanR by acetyl phosphate in ackA mutants. The reporter strains BW24267, BW24270, and BW24273 contain P araB -vanS ϩ , P araB -vanS H164Q , and no fusion, respectively, at the araCBAD locus; they also carry the P vanH -lacZ fusion and are phoB ϩ ⌬phoR ⌬creC, which allows us to monitor Bap synthesis as a measure of acetyl phosphate accumulation.
Substantial activation of VanR by acetyl phosphate occurs in the control strain BW24273 (ca. 450 U per cell OD 420 [ Table  7 ]). Activation is significantly reduced in the VanS strain BW24267 when grown without arabinose (ca. 150 U per cell OD 420 ). These cultures were grown on fructose media. Under these conditions, a small amount of VanS synthesis may result from leakiness of P araB causing (partial) dephosphorylation of P-VanR. No significant reduction is seen in the VanS H164Q strain BW24270 in the absence of arabinose, however.
In contrast, activation of VanR by acetyl phosphate is abolished (reduced ca. 7-fold) in the VanS H164Q strain upon induction with arabinose (ca. 60 and 430 U per cell OD 420 for BW24270 and BW24273, respectively [ Table 7 ]). The conserved H164 of VanS is therefore not required for dephosphorylation of P-VanR. Moreover, the addition of arabinose resulted in further activation of VanR by VanS. This is expected, as induction of VanS synthesis by arabinose also results in activation of VanR in the absence of acetyl phosphate (Table 3). Under all conditions, the same cultures produced similar amounts of Bap (Table 7) , thus ruling out an indirect effect on acetyl phosphate synthesis in these experiments.
DISCUSSION
We developed an E. coli model system for studying the VanS-VanR two-component regulatory system of Enterococcus faecium BM4147 that is required for type A inducible vancomycin resistance. Our system uses lacZ fusions to P vanH and P vanR . Activation of P vanH -lacZ transcriptional and translational fusions occurred when vanR was expressed from its native promoter and vanS was expressed from P araB . Under similar conditions, no positive or negative regulation of P vanR expression was apparent (Table 3 ). The absence of an effect on P vanR expression in our system suggests that the particular P vanR -lacZ fusion fails to mimic normal in vivo control or an unknown regulatory factor is not present.
Induction of VanS synthesis with arabinose in our P vanHlacZ reporter strains resulted in ca. 6-to 45-fold activation of VanR (Table 3) , depending on the fusion. Under these conditions, activation occurs in the absence of a (known) signal; activation probably results because VanS is being overproduced. Likewise, activation of PhoB by its partner PhoR also occurs in the absence of a signal (i.e., in the presence of excess P i ) when PhoR is synthesized at high levels from P araB (13 (15) .
Other in vitro studies have also shown that VanS is an autokinase and that P-VanS efficiently transfers its phosphate group to VanR (51) . These studies were carried out with a maltosebinding protein (MBP) fusion to the C-terminal cytosolic (M95 to S384) domain of VanS (denoted MBP-ЈVanS M95-S384 ). It was therefore unexpected that only full-length VanS, but not ЈVanS (VanS M95-S384 ), activates VanR in vivo (Table 3) . Possibly, ЈVanS M95-S384 adopts a different conformation than MBP-ЈVanS M95-S384 , preventing ЈVanS M95-S384 from phosphorylating VanR. Accordingly, ЈVanS M95-S384 may be inactive as a phosphotransferase toward VanR or more active as a P-VanR phosphatase. It is not especially surprising that alter- ation of the N terminus may affect its activity toward VanR. In the full-length protein, the N terminus is thought to regulate activity of the C-terminal kinase domain. An alternative possibility that ЈVanS M95-S384 is unstable in E. coli is unlikely; the same P araB -ЈvanS M95-S384 fusion results in the activation of mutant forms of PhoB (so-called PhoB AR proteins) under similar growth conditions (12) . The ability of ЈVanS to activate PhoB AR proteins, but not VanR, is compatible with the concept that partner kinase-response regulator interactions are regulated and that nonpartner interactions are unregulated. The inability of ЈPhoR M63-D431 to activate VanR is also understandable; the interaction of ЈPhoR M63-D431 with VanR is expected to be less efficient than the interaction of full-length PhoR with VanR because ЈPhoR M63-D431 is also less efficient than PhoR for activation of PhoB (13) .
The mechanisms of response regulator dephosphorylation differ in various systems, requiring in some cases additional proteins. In E. coli chemotaxis, P-CheY dephosphorylation requires CheZ and not the kinase CheA (34) . In B. subtilis sporulation, a separate protein, Spo0E, is the P-Spo0A phosphatase (28), while aspartyl phosphate phosphatases are also involved in dephosphorylation reactions of particular response regulators (30) . In E. coli nitrogen regulation, dephosphorylation of P-NtrC (NR I ) requires both GlnB(P II ) and the kinase NtrB (NR II ). In this case, the conserved histidine of NtrB is not required for dephosphorylation (18) . In E. coli osmoregulation, the conserved histidine of the Tar-EnvZ hybrid is required for P-OmpR dephosphorylation (53) . A mutant EnvZ also accepts phosphate from P-OmpR, suggesting that dephosphorylation occurs via a back transfer reaction (7). However, two laboratories have now shown that particular mutations of the conserved histidine of EnvZ do not abolish dephosphorylation (16, 36) . The conserved histidine of the kinase NarX is also not required for dephosphorylation of its partner response regulator (37) .
Like many signaling kinases, VanS is probably a P-VanR phosphatase. This conclusion is supported by earlier in vitro studies. P-VanR is relatively stable (half-life of 820 Ϯ 240 min); MBP-ЈVanS M95-S384 accelerates decomposition of PVanR ca. 6-fold (half-life of 120 min Ϯ 40 min), indicating that VanS acts as a P-VanR phosphatase (51) . The P-VanR phosphatase function is probably also responsible for the negative control of VanR by VanS in Enterococcus (1).
Our finding that VanR is activated by PhoR and acetyl phosphate in vivo provided an additional means for testing whether VanS is a P-VanR phosphatase. Indeed, we showed that VanS interferes with activation of VanR by PhoR and acetyl phosphate (Tables 4 and 6 ). Furthermore, we showed that the conserved histidine that is the autophosphorylation site of VanS (H164) is not required for this interference; VanS H164Q blocks activation of VanR by acetyl phosphate (Table 7) .
Two mechanisms can account for how VanS interferes with activation of VanR by PhoR and acetyl phosphate (Fig. 4) . By acting as a phosphatase, VanS may deactivate P-VanR by dephosphorylation. In this case, P-VanR dephosphorylation cannot require the conserved histidine because VanS H164Q carries out the same reaction. The dephosphorylation reaction therefore occurs by hydrolysis (Fig. 4A) . Alternatively, VanS may cause inhibition by tightly binding VanR and thereby preventing access of PhoR or acetyl phosphate to the VanR phosphorylation site (Fig. 4B) . Although we cannot rule out the second model, the former appears more likely as it is supported by in vitro studies (51) . Nonetheless, the latter remains a formal possibility.
Our results clearly show that VanS has dual roles in the control of VanR in vivo. When synthesized at a low level from P vanR or P araB in the absence of arabinose, VanS has a negative role. Under these conditions, VanS acts like a P-VanR phosphatase. However, when synthesized at a higher level from P araB in the presence of arabinose, or coexpressed with vanR from P rhaB in the presence of rhamnose, VanS has an activator role. Under the latter conditions, VanS acts as a VanR kinase (Tables 3 to 7 ). This activation occurs in the apparent absence of a signal. Therefore, VanS adopts different conformations in vivo. In one conformation, its P-VanR phosphatase predominates; in the other, its VanR kinase predominates. Furthermore, the interconversion of VanS between these forms may mimic its normal control in response to vancomycin in Enterococcus. PhoR also acts as an apparent P-PhoB phosphatase or PhoB kinase under similar synthesis conditions (13), suggesting that an interconversion may be a general phenomenon for membrane-associated two-component phosphatase-kinase proteins. Understanding the basis of the interconversion may provide an insight into the control of transmembrane signaling kinases. The interconversion of VanS between its two forms may be due to a change in its oligomeric state. Its P-VanR phosphatase may correspond to its monomeric (or low oligomeric) form, its VanR kinase may correspond to its dimeric (or higher oligomeric) form, or its P-VanR phosphatase may require the association of VanS with an unknown factor or specific membrane attachment site(s) that becomes limiting when VanS is present at high levels. Alternatively, its P-VanR phosphatase may require proper targeting of VanS to the membrane or folding of VanS within the membrane. This may occur only when VanS is at a low level. No compelling evidence or precedence now exists in favor of these or other possibilities. New biochemistry experiments are required to define the molecular basis of the switch between the P-VanR phosphatase and VanR kinase forms of VanS.
The use of an E. coli model system for studying vancomycin resistance provides both advantages and disadvantages. Our ability to examine both the VanR phosphotransferase and PVanR phosphatase functions of VanS required the use of several reporter strains and mutants not readily available in other bacteria. In some cases, it was also necessary to control synthesis levels in order to obtain meaningful results. Here again we benefited from the advantages of an E. coli model system. Type A vancomycin resistance of Enterococcus faecium BM4147 is inducible by vancomycin and the related glycopeptide antibiotic teicoplanin. The induction signal itself appears not to be a structural feature of vancomycin (21) . Rather, induction may be due to accumulation of a cell wall precursor, possibly a membrane-bound lipid intermediate (4) . Our present model system has not allowed us to test for effects of vancomycin or other glycopeptides on activation of VanS and VanR. As a gram-negative bacterium, E. coli is naturally resistant to these antibiotics due to the presence of an outer membrane. A number of vancomycin-sensitive E. coli mutants exist (22, 31, 33, 41) , however. To overcome this problem, we have now also developed vancomycin-sensitive E. coli reporter strains that may be useful to search for signal molecules that activate the VanS-VanR two-component regulatory system. By using our reporter strains, it may also be possible to identify cell wall biosynthetic mutants causing activation or inhibition as an additional means for tracking this signaling pathway.
The VanS-VanR signal transduction pathway leading to activation of the vanHAX genes involves at least four steps: (i) detection of a signal; (ii) activation of the VanS autokinase, leading to formation of P-VanS; (iii) phosphotransfer to form P-VanR; and (iv) transcriptional activation of P vanH by PVanR. An inhibitor that blocks this pathway may interfere with any of these steps. By using our E. coli reporter strains, it should be possible not only to search for signal molecules that activate the system but also to identify inhibitors that prevent activation. Such an inhibitor may prove useful in combating clinical resistance to vancomycin.
